Durvalumab Plus Gemcitabine/Cisplatin Approved by the FDA for Advanced or Metastatic Biliary Tract Cancers Prescribing information.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel Full Prescribing Information for Elahere:
Also find the prescribing information, announcements, resources, and channels to connect with Pfizer Medical Information. cisplatin or other platinum-
on Days 1 and 8 in combination with cisplatin therapy. Administer cisplatin intravenously at 100 mg/m2 on Day 1 after the infusion of Gemcitabine Injection. Refer to the cisplatin prescribing information for additional information. Reference ID:
WARNING: MYELOSUPPRESSION. See full prescribing information for complete boxed warning. cisplatin and 56% of patients treated with cisplatin had
Durvalumab Prescribing Information Gemcitabine Prescribing Information Cisplatin Prescribing Information. This regimen is most commonly used for biliary
Prescribing Information for additional Important Safety Information. Avastin in combination with paclitaxel and cisplatin or paclitaxel
See full prescribing information for information on preparation, cisplatin (greater than or equal to 70 mg/m2) based chemotherapy, there were two
CISPLATIN- cisplatin injection BluePoint Laboratories-HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CISPLATIN INJECTION, USP safely and effectively. See full prescribing information for CISPLATIN INJECTION, USP. CISPLATIN injection USP, for intravenous use Initial U.S. Approval: 2024
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.